Clinical Trials Sponsored by MAXIS, LLC

Total 10758 results

Protembis GmbH
MAXIS, LLC

Completed

The PROTEMBO SF Trial

Aortic Stenosis

Latvia, Ireland
Protembis GmbH
MAXIS Medical, LLC

Completed

The PROTEMBO C Trial

Valvular Heart Disease

Germany, Poland, Latvia
Hemovent GmbH
MAXIS Medical, LLC

Active, not recruiting

A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System of Cardiac and Respiratory Support: The MOBYBOX Trial

Respiratory Failure | Cardiac Failure | Cardio-Respiratory Failure

Germany
AIDAR Health, Inc.
MAXIS, LLC

Withdrawn

AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation (AIDI)

Sars-CoV-2 Infection

United States
neuroloop GmbH
MAXIS GmbH

Terminated

The Baroloop Study

Hypertension

Netherlands
Mexis George

Unknown

Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females (MEXISAREATA)

Alopecia Areata

Greece
Mexis George

Completed

Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females (MEXISPATENT)

Androgenetic Alopecia

Greece
Wiltrom Co., Ltd.
Maxis Medical GmbH

Recruiting

Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures

Osteoporotic Vertebral Compression Fractures

Germany
IRCCS Fondazione Stella Maris

Recruiting

Optical Imaging as a Tool for Monitoring Brain Function in Creatine Deficiency Syndromes

Creatine Deficiency, X-linked | Creatine Deficiency Syndrome Due to Gamt Deficiency

Italy
IRCCS Fondazione Stella Maris

Completed

Quality of Life in Children With Cerebral Palsy

Unilateral and Bilateral Cerebral Palsy

Italy
IRCCS Fondazione Stella Maris

Completed

A Study on Safety of tDCS One-shot in UCP

Hemiplegic Cerebral Palsy

Italy
IRCCS Fondazione Stella Maris

Recruiting

Optical Imaging as a Tool for Monitoring Brain Function in Fragile X Syndrome

Fragile X Syndrome

Italy
IRCCS Fondazione Stella Maris

Completed

Testing Miglustat Administration in Subjects With Spastic Paraplegia 11 (TreatSPG11)

Hereditary Spastic Paraparesis

Italy
IRCCS Fondazione Stella Maris

Completed

Early Identification of Infants at Risk of Cerebral Palsy

Cerebral Palsy | Preterm Infant

Italy
IRCCS Fondazione Stella Maris

Recruiting

Speech Motor Treatment in Cerebral Palsy

Cerebral Palsy | Dysarthria

Italy
IRCCS Fondazione Stella Maris

Completed

Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11) (3AL-SPG11)

Hereditary Spastic Paraplegia | Spastic Paraplegia Type 11

Italy
IRCCS Fondazione Stella Maris

Completed

Trehalose in Subjects With Neuronal Ceroid Lipofuscinoses (3AL-CLN36)

Neuronal Ceroid-Lipofuscinoses

Italy
IRCCS Fondazione Stella Maris

Completed

CareToy Early Intervention in Infants at Risk for Cerebral Palsy

Cerebral Palsy

Italy
Axis Shield Diagnostics Ltd

Terminated

Sepsis Assessment in Belgian Emergency Rooms (SABER)

Sepsis | Shock, Septic | Severe Sepsis

Belgium
Axis Shield Diagnostics Ltd

Completed

IMproved PREdiction of Severe Sepsis in the Emergency Department (IMPRESSED)

Sepsis | Septic Shock | Severe Sepsis | Systemic Inflammatory Response Syndrome (SIRS)

United States, Sweden
Xenios AG
MAXIS Medical

Completed

Synchronized Cardiac Assist for Cardiogenic Shock

Shock, Cardiogenic | High Risk Percutaneous Coronary Interventions

Germany
John Maris

Available

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Neuroblastoma | Childhood Metastatic Pheochromocytoma

United States
Maxim Pharmaceuticals
National Cancer Institute (NCI)

Unknown

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver

Metastatic Cancer | Melanoma (Skin)

United States, Canada, Germany, United Kingdom
IRCCS Fondazione Stella Maris
BioRobotics Institute

Completed

AOT and ICT for Hemiplegia (Tele-UPCAT)

Hemiplegia | Hemiplegic Cerebral Palsy

Italy
Maxim Pharmaceuticals

Completed

Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia

Leukemia

United States, France, Israel, Australia, Canada, Sweden, Finland, Germany, New Zealand, Denmark, Estonia, United Kingdom
IRCCS Fondazione Stella Maris
University of Pisa

Completed

Mindfulness-based Program for Children With Disruptive Behavior Disorder

Attention Deficit and Disruptive Behavior Disorders | Oppositional Defiant Disorder | Disruptive Behavior Disorder

Italy
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Solid Tumor | Hematological Malignancies

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes

Solid Tumors | Hematological Malignancies

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Terminated

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Relapsed/Refractory Solid Tumors/Hematological Malignancies

United States
Aurobindo Pharma Ltd
Axis Clinicals Limited

Completed

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

Visceral Leishmaniasis

Bangladesh, India
Xspray Pharma AB
Axis Clinicals Limited

Completed

Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions

Pharmacokinetics | Drug Interactions

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)

Peripheral T-Cell Lymphoma (PTCL)

United States
Maxim Canet Vintró

Recruiting

Tecarterapy on the Performance of Amateur Athletes.

Sports Physical Therapy | Diathermy Plate Burn

Spain
Acrotech Biopharma Inc.
Axis Clinicals Limited

Unknown

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Hematologic Diseases
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies

Refractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma

United States
Arthritis Northwest PLLC
Epigenesys LLC

Unknown

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

Arthritis, Rheumatoid

United States
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Meyer Children's Hospital IRCCS
IRCCS Fondazione Stella Maris

Recruiting

Children Born Preterm: Sustainable Health Monitoring

Premature Birth

Italy
IRCCS Fondazione Stella Maris
Azienda Ospedaliero, Universitaria Pisana

Completed

Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?

Epilepsy | Multiple Sclerosis | Neurodegenerative Diseases | Neurodevelopmental Disorders | Brain Tumor

Italy
IRCCS Fondazione Stella Maris
Ministry of Health, Italy

Completed

Childhood Apraxia of Speech: Experience Dependent Changes Induced by Treatment (CAS)

Childhood Apraxia of Speech

Italy
Mayo Clinic
Gargar Clinic; Axis Medical Center

Completed

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

Hepatitis B | Carcinoma, Hepatocellular | Hepatitis C

United States
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple
Dana-Farber Cancer Institute
Hans and Mavis Lopater Foundation

Active, not recruiting

RCT of CBD for Anxiety in Advanced Breast Cancer

Advanced Breast Cancer | Anxiety | CBD

United States
LLS PedAL Initiative, LLC
Kura Oncology

Not yet recruiting

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Relapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
Axis Shield Diagnostics Ltd
The Clinical Trial Company

Completed

Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA Centaur PAPPA and BhCG Assays

Trisomy 21 in Fetus | Trisomy 18 in Fetus | Trisomy 13 in Fetus

United Kingdom
MedRegen LLC
Johns Hopkins University; ICON plc

Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

COVID-19 | ARDS, Human | Regeneration | Stem Cells

United States
IRCCS Fondazione Stella Maris
University of Parma; IRCCS reggio emilia

Not yet recruiting

Action Observation in Children With Diplegic Cerebral Palsy

Diplegic Cerebral Palsy

Italy
Redx Pharma Plc
Merck Sharp & Dohme LLC

Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)

Advanced Solid Tumours

United Kingdom, Australia

Clinical Trials Sponsored by MAXIS, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations